Page 12 - Annual Report 2018

▄▀ 1.3 Letter from the Managing Director Mª Ángeles Pérez

more year, to take stock of the activity of the CIEN
Foundation and highlight the milestones that have
marked this year.
The CIEN Foundation is a reference in basic, clinical
and epidemiological neurology, both due to our
translational research projects as well as to the in-
ternationalization of our activities. After more than
10 years developing our work at the Queen Sofia
Foundation Alzheimer Center, we lead the investi-
gation in neurodegenerative diseases, something
that would not be possible without the unconditio-
nal support of Queen Sofia Foundation and the Car-
los III Institute of Health (ISCIII).

Thus, one of the most important milestones achieved
during 2018 has been the signing of a collaboration
agreement between the CIEN Foundation and the
Queen Sofia Foundation to raise public awareness
about the importance of promoting research in neu-
rodegenerative diseases. Under the name
Neuro2020: "Neurodegenerative diseases 2020. In-
ternational Year of Research and Innovation", both
institutions also seek to create a platform for the ge-
neration of ideas and the exchange of experiences
between experts from around the world and contri-
bute to Spain being among the leading countries in
international scientific research in this field.

Regarding the scientific productivity of the CIEN
Foundation in 2018, the conscientious research work
carried out by our team of professionals has led to
the publication of 25 original articles in specialized
journals, 80% of them in journals ranked first and
second quartile Together with the publication of
new articles, the CIEN Foundation has promoted the
The year 2018 has been an exercise in progress and expansion of scientific knowledge through the or-
consolidation. The ongoing projects and our rese- ganization, jointly with the Queen Sofia Foundation
arch work devoted to the benefit of society conti- and the Network Center for Biomedical Research in
nue moving forward to find solutions to one of the Neurodegenerative Diseases (CIBERNED), of the VI
main threats of the 21st century: Alzheimer's disease. edition of the International Congress of Research
Therefore, it is an honor for me to address you, one and Innovation in Neurodegenerative Diseases

María Ángeles Pérez Muñoz
CIEN Foundation Managing Director